Literature DB >> 32084364

Implication of HYBID (Hyaluronan-Binding Protein Involved in Hyaluronan Depolymerization) in Hyaluronan Degradation by Synovial Fibroblasts in Patients with Knee Osteoarthritis.

Jun Shiozawa1, Susana de Vega2, Mehmet Z Cilek3, Chiho Yoshinaga2, Tomomi Nakamura4, Shinya Kasamatsu4, Hiroyuki Yoshida4, Haruka Kaneko5, Muneaki Ishijima6, Kazuo Kaneko7, Yasunori Okada8.   

Abstract

Cell migration-inducing hyaluronidase 1 (CEMIP), also known as hyaluronan (HA)-binding protein involved in HA depolymerization (HYBID), plays a role in HA degradation. CEMIP2, also known as transmembrane protein 2 (TMEM2), possessing a sequence similarity with HYBID, is reported as a hyaluronidase in mice. However, the expression of these molecules in osteoarthritic synovium and their involvement in HA degradation in synovial fluid (SF) from patients with knee osteoarthritis remain elusive. This study examined their expression in synovial tissue and the relationship with molecular weight of HA in SF in knee osteoarthritis patients. Quantification of mRNA demonstrated that HYBID expression is significantly (5.5-fold) higher in osteoarthritic synovium than in normal control synovium, whereas TMEM2 expression level is similar between the two groups. By immunohistochemistry, HYBID was localized mainly to CD68-negative and fibroblast-specific protein 1-positive synovial lining cells and sublining fibroblasts in osteoarthritic synovium. The mRNA expression levels of HYBID, but not TMEM2, in osteoarthritic synovium positively correlated with distribution of lower-molecular-weight HA with below 1000 kDa in SF. HA-degrading activity in osteoarthritic synovial fibroblasts was abrogated by siRNA-mediated knockdown of HYBID. Among the 12 factors examined, IL-6 significantly up-regulated the HYBID expression and HA-degrading activity in osteoarthritic synovial fibroblasts. These data suggest that HYBID overexpressed by IL-6-stimulated synovial fibroblasts is implicated in HA degradation in osteoarthritic synovium.
Copyright © 2020 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Year:  2020        PMID: 32084364     DOI: 10.1016/j.ajpath.2020.01.003

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  8 in total

1.  Possible Repositioning of an Oral Anti-Osteoporotic Drug, Ipriflavone, for Treatment of Inflammatory Arthritis via Inhibitory Activity of KIAA1199, a Novel Potent Hyaluronidase.

Authors:  Hiroshi Koike; Yoshihiro Nishida; Tamayuki Shinomura; Bisei Ohkawara; Kinji Ohno; Lisheng Zhuo; Koji Kimata; Takahiro Ushida; Shiro Imagama
Journal:  Int J Mol Sci       Date:  2022-04-07       Impact factor: 6.208

2.  CEMIP (KIAA1199) regulates inflammation, hyperplasia and fibrosis in osteoarthritis synovial membrane.

Authors:  Michel G Malaise; Dominique de Seny; Céline Deroyer; Christophe Poulet; Geneviève Paulissen; Federica Ciregia; Olivier Malaise; Zelda Plener; Gaël Cobraiville; Christophe Daniel; Philippe Gillet
Journal:  Cell Mol Life Sci       Date:  2022-04-27       Impact factor: 9.207

3.  Induction of CEMIP in Chondrocytes by Inflammatory Cytokines: Underlying Mechanisms and Potential Involvement in Osteoarthritis.

Authors:  Takashi Ohtsuki; Omer F Hatipoglu; Keiichi Asano; Junko Inagaki; Keiichiro Nishida; Satoshi Hirohata
Journal:  Int J Mol Sci       Date:  2020-04-29       Impact factor: 5.923

4.  Abundance and size of hyaluronan in naked mole-rat tissues and plasma.

Authors:  Delphine Del Marmol; Susanne Holtze; Nadia Kichler; Arne Sahm; Benoit Bihin; Virginie Bourguignon; Sophie Dogné; Karol Szafranski; Thomas Bernd Hildebrandt; Bruno Flamion
Journal:  Sci Rep       Date:  2021-04-12       Impact factor: 4.379

Review 5.  Engineering Hyaluronic Acid for the Development of New Treatment Strategies for Osteoarthritis.

Authors:  Yu Seon Kim; Farshid Guilak
Journal:  Int J Mol Sci       Date:  2022-08-04       Impact factor: 6.208

6.  Expression and regulation of recently discovered hyaluronidases, HYBID and TMEM2, in chondrocytes from knee osteoarthritic cartilage.

Authors:  Jun Shiozawa; Susana de Vega; Chiho Yoshinaga; Xang Ji; Yoshifumi Negishi; Masahiro Momoeda; Tomomi Nakamura; Hiroyuki Yoshida; Haruka Kaneko; Muneaki Ishijima; Yasunori Okada
Journal:  Sci Rep       Date:  2022-10-14       Impact factor: 4.996

Review 7.  Hyaluronan: Metabolism and Function.

Authors:  Takashi Kobayashi; Theerawut Chanmee; Naoki Itano
Journal:  Biomolecules       Date:  2020-11-07

Review 8.  Targeting Cell Death: Pyroptosis, Ferroptosis, Apoptosis and Necroptosis in Osteoarthritis.

Authors:  Jian Yang; Shasha Hu; Yangyang Bian; Jiangling Yao; Dong Wang; Xiaoqian Liu; Zhengdong Guo; Siyuan Zhang; Lei Peng
Journal:  Front Cell Dev Biol       Date:  2022-01-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.